Resultados da busca - Andrea De Giglio

  • Mostrando 1 - 15 resultados de 15
Refinar Resultados
  1. 1
    The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)

    The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines) por Andrea De Giglio, Alessandro Di Federico, Giacomo Nuvola, Chiara Deiana, Francesco Gelsomino

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond

    Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond por Mirta Mosca, Maria Concetta Nigro, Rachele Pagani, Andrea De Giglio, Alessandro Di Federico

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

    Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians por Emanuel Raschi, Simone Rossi, Andrea De Giglio, Michele Fusaroli, Flavio Burgazzi, Rita Rinaldi, Luciano Potena

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes

    Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes por Alessandro Di Federico, Mirta Mosca, Rachele Pagani, Riccardo Carloni, Giorgio Frega, Andrea De Giglio, Alessandro Rizzo, Dalia Ricci, Simona Tavolari, Mariacristina Di Marco, Andrea Palloni, Giovanni Brandi

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Peripheral nervous system adverse events associated with immune checkpoint inhibitors

    Peripheral nervous system adverse events associated with immune checkpoint inhibitors por Simone Rossi, Francesco Gelsomino, Rita Rinaldi, Lorenzo Muccioli, Francesca Comito, Alessandro Di Federico, Andrea De Giglio, Giuseppe Lamberti, Elisa Andrini, Veronica Mollica, Roberto D’Angelo, Flavia Baccari, Corrado Zenesini, Pierandrea Madia, Emanuel Raschi, Pietro Cortelli, Andrea Ardizzoni, Maria Guarino

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

    Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis por Hamzah Abu‐Sbeih, Faisal S. Ali, Abdul Rafeh Naqash, Dwight H. Owen, Sandipkumar Patel, Gregory A. Otterson, Kari Kendra, Biagio Ricciuti, Rita Chiari, Andrea De Giglio, Joseph Sleiman, Pauline Funchain, Wills Beatriz, Jiajia Zhang, Jarushka Naidoo, Jessica Philpott, Jianjun Gao, Sumit K. Subudhi, Yinghong Wang

    Publicado em 2019
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)

    Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI) por Andrea De Giglio, Laura Mezquita, Édouard Auclin, Félix Blanc‐Durand, Mariona Riudavets, Caroline Caramella, G Burón Martínez, José Carlos Benítez, Patricia Martín-Romano, Lamiae El-Amarti, Lizza Hendriks, Roberto Ferrara, Charles Naltet, Pernelle Lavaud, Anas Gazzah, Julien Adam, David Planchard, Nathalie Chaput, Benjamin Besse

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

    Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian e... por Elena Verzoni, Giacomo Cartenì, Enrico Cortesi, Diana Giannarelli, Andrea De Giglio, Roberto Sabbatini, Sebastiano Buti, Sabrina Rossetti, Francesco Cognetti, Francesca Rastelli, Alberto F. Sobrero, D. Turci, Cora N. Sternberg, Camillo Porta, Federico Cappuzzo, Giampaolo Tortora, Davide Tassinari, Stefano Panni, Antonio Pazzola, Gianmarco Surico, Alessandra Raimondi, Ugo De Giorgi, Giuseppe Procopio

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations

    Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations por Mariona Riudavets, Édouard Auclin, Miguel Mosteiro, Naomi Dempsey, Margarita Majem, Riccardo Lobefaro, Rafael López Castro, Joaquím Bosch-Barrera, Sara Pilotto, E. Escalera, Marco Tagliamento, Joaquín Mosquera, Gérard Zalcman, Frank Aboubakar Nana, Santiago Ponce, Alessandro Dal Maso, Martina Spotti, Xabier Mielgo-Rubio, Elodie Mussat, Roxana Reyes, José Carlos Benítez, Lorena Lupinacci, Boris Duchemann, Andrea De Giglio, Juan Bautista Blaquier, Clarisse Audigier-Valette, Matthias Scheffler, Ernest Nadal, Gilberto Lopes, Diego Signorelli, Rosario García‐Campelo, Jessica Menis, Virginia Bluthgen, Marc Campayo, Gonzalo Recondo, Benjamin Besse, David Planchard, Laura Mezquita

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

    A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable por Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, Katia Cannita, Daniele Santini, Fabiana Perrone, Raffaele Giusti, Marcello Tiseo, Maria Michiara, Pietro Di Marino, Nicola Tinari, Michele De Tursi, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Francesco Malorgio, Marco Russano, Cecilia Anesi, Tea Zeppola, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Gian Carlo Antonini Cappellini, Federica De Galitiis, Maria Giuseppa Vitale, Francesca Rastelli, Federica Pergolesi, Rossana Berardi, Silvia Rinaldi, Marianna Tudini, Rosa Rita Silva, Annagrazia Pireddu, Francesco Atzori, Rita Chiari, Biagio Ricciuti, Andrea De Giglio, Daniela Iacono, Alain Gelibter, Mario Occhipinti, Alessandro Parisi, Giampiero Porzio, Maria Concetta Fargnoli, Paolo A. Ascierto, Corrado Ficorella, Clara Natoli

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer

    The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer por Giuseppe Luigi Banna, Alessio Cortellini, Diego Cortinovis, Marcello Tiseo, Joachim G.J.V. Aerts, Fausto Barbieri, Raffaele Giusti, Emilio Bria, Francesco Grossi, Pamela Pizzutilo, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Marianna Macerelli, Francesca Rastelli, Rita Chiari, Danilo Rocco, Stefania Gori, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Rosanna De Marco, Luca Cantini, Olga Nigro, Ettore D’Argento, Sebastiano Buti, Gabriele Minuti, Lorenza Landi, Giorgia Guaitoli, Giuseppe Lo Russo, Alessandro De Toma, Clelia Donisi, Alex Friedlaender, Andrea De Giglio, Giulio Metro, Giampiero Porzio, Corrado Ficorella, Alfredo Addeo

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’

    Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-ce... por Giuseppe Luigi Banna, Alessio Cortellini, Diego Cortinovis, Marcello Tiseo, J.G.J.V. Aerts, Fausto Barbieri, Raffaele Giusti, Emilio Bria, Francesco Grossi, Pamela Pizzutilo, R. Berardi, Antonino Morabito, Carlo Genova, Francesca Mazzoni, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Marianna Macerelli, Francesca Rastelli, Rita Chiari, Danilo Rocco, Stefania Gori, Michele De Tursi, Pietro Di Marino, Gelsomina Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Ranieri Vito Marco, Luca Cantini, Olga Nigro, Ettore D’Argento, Sebastiano Buti, Gabriele Minuti, Lorenza Landi, Giorgia Guaitoli, Giuseppe Lo Russo, Alessandro De Toma, Clelia Donisi, Alex Friedlaender, Andrea De Giglio, Giulio Metro, Giampiero Porzio, Corrado Ficorella, Alfredo Addeo

    Publicado em 2021
    Obter o texto integral
    Errata/Corrigenda
    Salvar na lista
    Na minha lista:
  13. 13
    Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

    Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study por Olga Nigro, Graziella Pinotti, Federica De Galitiis, Francesca Romana Di Pietro, Raffaele Giusti, Marco Filetti, Melissa Bersanelli, Alessandro Lazzarin, Paola Bordi, Annamaria Catino, Pamela Pizzutilo, Domenico Galetta, Paolo Marchetti, Andrea Botticelli, Simone Scagnoli, Marco Russano, Daniele Santini, Mariangela Torniai, Rossana Berardi, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Alessandro Russo, Vincenzo Adamo, Marianna Tudini, Rosa Rita Silva, Elena Bolzacchini, Monica Giordano, Pietro Di Marino, Michele De Tursi, Erika Rijavec, Michele Ghidini, I. Vallini, Luigia Stefania Stucci, Marco Tucci, Laura Pala, Fabio Conforti, Paola Queirolo, Enrica T. Tanda, Francesco Spagnolo, Federica Cecchi, Sergio Bracarda, Serena Macrini, Matteo Santoni, Nicola Battelli, Maria Concetta Fargnoli, Giampiero Porzio, Alessandro Tuzi, Matteo B. Suter, Corrado Ficorella, Alessio Cortellini

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Smoking status during first‐line immunotherapy and chemotherapy in <scp>NSCLC</scp> patients: A case–control matched analysis from a large multicenter study

    Smoking status during first‐line immunotherapy and chemotherapy in <scp>NSCLC</scp> patients: A case–control matched analysis from a large multicenter study por Alessio Cortellini, Andrea De Giglio, Katia Cannita, Diego Cortinovis, Robin Cornelissen, Cinzia Baldessari, Raffaele Giusti, Ettore D’Argento, Francesco Grossi, Matteo Santoni, Annamaria Catino, Rossana Berardi, Vincenzo Sforza, Giovanni Rossi, Lorenzo Antonuzzo, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Mario Occhipinti, Alessandro Follador, Francesca Rastelli, Rita Chiari, Luigi Della Gravara, Alessandro Inno, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Maria Vittoria Pensieri, Marco Russano, Luca Cantini, Olga Nigro, Alessandro Leonetti, Paola Bordi, Gabriele Minuti, Lorenza Landi, Alessandro De Toma, Clelia Donisi, Serena Ricciardi, Maria Rita Migliorino, Valerio Maria Napoli, Gianmarco Leone, Giulio Metro, Giuseppe Luigi Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry

    Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y glo... por Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J. Pinato, Jarushka Naidoo, Artur Katz, Matthew J. Loza, Joel W. Neal, Carlo Genova, Scott Gettinger, So Yeon Kim, Ritujith Jayakrishnan, Talal El Zarif, Marco Russano, Federica Pecci, Alessandro Di Federico, Mark M. Awad, Joao V. Alessi, Michele Montrone, Dwight H. Owen, Diego Signorelli, Mary J. Fidler, Mingjia Li, Andrea Camerini, Andrea De Giglio, Lauren Young, Bruno Vincenzi, Giulio Metro, Francesco Passiglia, Sai Yendamuri, Annalisa Guida, Michele Ghidini, Nichola Awosika, Andrea Napolitano, Claudia A M Fulgenzi, Salvatore Grisanti, Francesco Grossi, Armida D’Incecco, Eleni Josephides, Mieke Van Hemelrijck, Alessandro Russo, Alain Gelibter, Gianpaolo Spinelli, Monica Verrico, Bartłomiej Tomasik, Raffaele Giusti, Thomas Newsom-Davis, Emilio Bria, Martin Sebastian, Maximilian Rost, Martin Förster, Uma Mukherjee, Lorenza Landi, Francesca Mazzoni, Avinash Aujayeb, Madeleine Dupont, Alessandra Curioni‐Fontecedro, Rita Chiari, Francesco Pantano, Alessandro Morabito, Alessandro Leonetti, Alex Friedlaender, Alfredo Addeo, Federica Zoratto, Michele De Tursi, Luca Cantini, Elisa Roca, Giannis Mountzios, Luigi Della Gravara, Sukumar Kalvapudi, Alessandro Inno, Paolo Bironzo, Rita Barros, David O’Reilly, Jack Bell, Eleni Karapanagiotou, Isabelle Monnet, Javier Baena Preysler, Marianna Macerelli, Margarita Majem, Francesco Agustoni, Diego Cortinovis, Giuseppe Tonini, Gabriele Minuti, Chiara Bennati, Laura Mezquita, Teresa Gorría, Alberto Servetto, Teresa Beninato, Giuseppe Lo Russo, Jacobo Rogado, Laura Moliner, Federica Biello, Frank Aboubakar Nana, Anne‐Marie C. Dingemans, Joachim G.J.V. Aerts, Roberto Ferrara, Valter Torri, Taher Abu Hejleh

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: